Le Lézard6h
Lilly confirms date and conference call for fourth-quarter 2024 financial results and 2025 financial guidance announcement
Eli Lilly and Company will announce its fourth-quarter 2024 financial results and 2025 financial guidance on Feb. 6, 2025. Lilly will also conduct a conference call that day with the investment ...
Eli Lilly & Co’s Promising Growth: Accelerated Revenue and Drug Pipeline Advances
DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating on January 21.Invest with Confidence: Follow ...
Pliant Therapeutics, Inc.: Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer
Dr. Imbert brings 25 years of strategic clinical to commercial-stage manufacturing and drug development experience SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, ...
Upbeat Earnings News May Lead To Strength On Wall Street
The major U.S. index futures are currently pointing to a higher open on Wednesday, with stocks likely to add to the gains posted in ...
Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer
Detailed price information for Pliant Therapeutics Inc (PLRX-Q) from The Globe and Mail including charting and trades.
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.
Chinese biotech dominance in R&D is on the rise
According to Evaluate Pharma, China's growing influence in pharmaceutical R&D is a key theme to watch in 2025. The pharma ...
Biologics Contract Development And Manufacturing Organization (CDMO) Market , 58% of Growth to Originate from North America, Technavio
The global biologics contract development and manufacturing organization (cdmo) market size is estimated to grow by USD 16.32 ...